Skip Nav Destination

TLR7 F507S gain-of-function mutation presenting with early-onset SLE and hypertriglyceridemia: Response to JAK inhibition

J Hum Immun (2026) 2 (2): e20250196.
Currently there are no citedby results. Try again later.